Zobrazeno 1 - 10
of 56
pro vyhledávání: '"I. Kezic"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Immunoinflammatory biomarkers and skin barrier function in atopic dermatitis (AD) may be crucial for monitoring disease activity and patient stratification. Commonly, biomarkers are determined from blood or stratum corneum (SC), but comparative studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::217d67700d4319e1eb58748f5feb33b1
https://www.bib.irb.hr/1233025
https://www.bib.irb.hr/1233025
Autor:
P. Van der Ark, Gabriel E. Jacobs, I. Kezic, J.M.A. van Gerven, Sander Brooks, A Savitz, Rob Zuiker
Publikováno v:
Sleep. 44:A136-A136
Introduction Seltorexant (JNJ-42847922), a potent and selective antagonist of the human orexin-2 receptor, is being developed for the treatment of major depressive disorder. Seltorexant also has sleep-promoting properties. Investigating the effects o
Autor:
I. Kezic, Sander Brooks, Rob Zuiker, Joop M. A. van Gerven, Peter de Boer, Wayne C. Drevets, Remy Luthringer, Peter van der Ark, Justine M. Kent, Luc Van Nueten, Guido van Amerongen, Gabriel E. Jacobs
Publikováno v:
Journal of Psychopharmacology, 33(2), 202-209
Background: Insomnia is common in patients with major depressive disorder. Although antidepressants improve mood, insomnia often persists as a result of physiological hyperarousal. The orexin-2 receptor is increasingly being recognized as a new targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8373ae9a16200258305ec1e18d2b3cf
https://hdl.handle.net/1887/119782
https://hdl.handle.net/1887/119782
Autor:
Joop M. A. van Gerven, Peter de Boer, Christian Keicher, Georg Dorffner, Hany Rofael, Remy Luthringer, Peter van der Ark, Holger Jahn, Wayne C. Drevets, Justine M. Kent, Heike Benes, I. Kezic, Silvia Parapatics, David J Seiden
Publikováno v:
Journal of Psychopharmacology, 32(6), 668-677
Background: Seltorexant is a potent and selective antagonist of the orexin-2 receptor that is being developed for the treatment of insomnia and major depressive disorder. Aims: The primary objective was to investigate the effect of seltorexant on sle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b56c1f9fd62987d301a5045bd39ff0
https://hdl.handle.net/1887/96083
https://hdl.handle.net/1887/96083
Autor:
Heidi De Smedt, Hiba Salih, Eef Hoeben, Peter de Boer, Ion Anghelescu, Luc Van Nueten, I. Kezic, Vikash K. Sinha
Publikováno v:
Journal of Psychopharmacology. 29:414-425
Metabotropic glutamate receptor-2 positive allosteric modulator, JNJ-40411813 (ADX71149), was characterised for clinical effects in healthy volunteers in two phase-1 studies. In study 1, healthy men received 50-, 100-, 150- or 225 mg and women receiv
Autor:
Jakasa I, Kezic S
The skin acts as a protective and regulatory barrier between the body and the environment. The main barrier function resides in the outermost layer of the epidermis, stratum corneum (SC) which is composed of anucleated flattened cells corneocytes, bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::463dc532f9b8acaf4434d0fffb3f94ec
https://www.bib.irb.hr/872926
https://www.bib.irb.hr/872926
Autor:
P. De Boer, Justine M. Kent, G. Van Amerongen, Remy Luthringer, P. Van der Ark, J.M.A. van Gerven, Sander Brooks, I. Kezic, Gabriel E. Jacobs
Publikováno v:
European Neuropsychopharmacology. 26:S408-S409
Autor:
J. Citic, Ana Cvetanovic, Z. Murtezani, I. Kezic, S. Susnjar, G. Matovina-Brko, A. Stojanovic, Siniša Radulović, Dusica Gavrilovic, N. Milosavljevic, N. Nedovic, I. Kolarov-Bjelobrk, Lazar Popovic, M. Popovic, N. Stanic, K. Serovic
Publikováno v:
European Journal of Cancer. 92:S112
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.